Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate

Yung-Tuen Chiu1, Ji Liu, Kaidun Tang

  • 1Department of Anatomy, The University of Hong Kong, Hong Kong, Special Administrative Region, China.

Plos One
|December 29, 2012
PubMed

Insights

The ATM/ATR DNA damage checkpoint is crucial for genetic stability. Its inactivation promotes prostate cancer by enabling androgen-induced genomic instability and specific gene rearrangements.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The ATM/ATR DNA damage checkpoint is vital for maintaining genetic stability.
  • Some ATM gene variants are linked to increased prostate cancer risk, but direct causal links remain unclear.

Purpose of the Study:

  • To investigate the role of the ATM/ATR DNA damage checkpoint in prostate cancer predisposition.
  • To determine if ATM/ATR inactivation contributes to androgen-induced genomic instability in prostate cells.

Main Methods:

  • Exposure of non-malignant prostate epithelial cells (HPr-1AR) to androgen.
  • Knockdown of ATM gene expression.
  • Analysis of TMPRSS2:ERG rearrangement and DNA damage response pathways (ATM/ATR, H2AX, CHK1/CHK2, p53).

Main Results:

  • Androgen exposure activates ATM/ATR and induces senescence in normal prostate cells.
  • ATM knockdown promotes androgen-induced TMPRSS2:ERG rearrangement.
  • Prostate cancer cells exhibit defective ATM/ATR checkpoint response to androgen, with partial DNA damage response activation.

Conclusions:

  • ATM/ATR inactivation is a critical event in promoting androgen-induced genomic instability.
  • This inactivation facilitates prostate carcinogenesis by enabling specific chromosomal translocations.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...